Pdt Partners, LLC 4 D Molecular Therapeutics, Inc. Transaction History
Pdt Partners, LLC
- $1.58 Billion
- Q2 2025
A detailed history of Pdt Partners, LLC transactions in 4 D Molecular Therapeutics, Inc. stock. As of the latest transaction made, Pdt Partners, LLC holds 20,097 shares of FDMT stock, worth $175,848. This represents 0.0% of its overall portfolio holdings.
Number of Shares
20,097
Previous 54,999
63.46%
Holding current value
$175,848
Previous $177,000
58.19%
% of portfolio
0.0%
Previous 0.01%
Shares
8 transactions
Others Institutions Holding FDMT
# of Institutions
124Shares Held
41.2MCall Options Held
19KPut Options Held
38.3K-
Black Rock Inc. New York, NY4.9MShares$42.8 Million0.0% of portfolio
-
Bvf Inc San Francisco, CA4.63MShares$40.5 Million0.67% of portfolio
-
Ra Capital Management, L.P. Boston, MA4.56MShares$39.9 Million0.37% of portfolio
-
Goldman Sachs Group Inc New York, NY4.16MShares$36.4 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.74MShares$23.9 Million0.0% of portfolio
About 4D Molecular Therapeutics, Inc.
- Ticker FDMT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 32,382,400
- Market Cap $283M
- Description
- 4D Molecular Therapeutics, Inc., a clinical-stage gene therapy company, develops product candidates using its adeno-associated viruses vectors. It develops a portfolio of gene therapy product candidates focuses in three therapeutic areas: ophthalmology, cardiology, and pulmonology. The company has three product candidates that are in clinical tr...